96 related articles for article (PubMed ID: 7519907)
1. Primary culture of smooth muscle cells from benign prostatic hyperplasia.
Wu YX; Kawabe K
J Smooth Muscle Res; 1994 Apr; 30(2):51-6. PubMed ID: 7519907
[TBL] [Abstract][Full Text] [Related]
2. Stromal cells of the human prostate: initial isolation and characterization.
Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
[TBL] [Abstract][Full Text] [Related]
3. Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers.
Zhang J; Hess MW; Thurnher M; Hobisch A; Radmayr C; Cronauer MV; Hittmair A; Culig Z; Bartsch G; Klocker H
Prostate; 1997 Feb; 30(2):117-29. PubMed ID: 9051150
[TBL] [Abstract][Full Text] [Related]
4. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
[TBL] [Abstract][Full Text] [Related]
5. Cultured circular smooth muscle from the rabbit colon.
Kao HW; Finn SE; Gown AM; Lechago J; Lachant N; Snape WJ
In Vitro Cell Dev Biol; 1988 Aug; 24(8):787-94. PubMed ID: 3045072
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
8. Differential growth rates in stromal cultures of human prostate derived from patients of varying ages.
Sensibar JA; Pruden SJ; Kasjanski RZ; Rademaker A; Lee C; Grayhack JT; Kozlowski JM
Prostate; 1999 Feb; 38(2):110-7. PubMed ID: 9973096
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia.
Eckert RE; Schreier U; Drescher P; Madsen PO; Derouet H; Becht E; Steffens J; Ziegler M
Urol Int; 1995; 54(1):6-21. PubMed ID: 7539557
[TBL] [Abstract][Full Text] [Related]
10. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
[TBL] [Abstract][Full Text] [Related]
11. Development of a cell-isolation method for human prostatic smooth muscle cells based on cell type-specific activation of the SM22 gene promoter.
Wang CY; Shi JD; Yan CH; Wu Q; Klocker H; Park I; Lee C; Zhang J
BJU Int; 2007 Jan; 99(1):183-8. PubMed ID: 17034489
[TBL] [Abstract][Full Text] [Related]
12. Cellular localization of fibroblast growth factor 2 (FGF-2) in benign prostatic hyperplasia.
Sinowatz F; Schams D; Einspanier R; Arnold G; Pfeffer M; Temmim-Baker L; Amselgruber W; Plendl J
Histol Histopathol; 2000 Apr; 15(2):475-81. PubMed ID: 10809367
[TBL] [Abstract][Full Text] [Related]
13. Functional property, norepinephrine content and morphometric findings in human hyperplastic prostate.
Ishigooka M; Hashimoto T; Suzuki Y; Ichiyanagi O; Sasagawa I; Aoyama N; Nakada T
Prostate; 1997 Nov; 33(3):183-7. PubMed ID: 9365546
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
15. The prevention of benign prostatic hyperplasia (bph).
Roper WG
Med Hypotheses; 2017 Mar; 100():4-9. PubMed ID: 28236846
[TBL] [Abstract][Full Text] [Related]
16. Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects.
Kügler R; Mietens A; Seidensticker M; Tasch S; Wagenlehner FM; Kaschtanow A; Tjahjono Y; Tomczyk CU; Beyer D; Risbridger GP; Exintaris B; Ellem SJ; Middendorff R
FASEB J; 2018 Mar; 32(3):1130-1138. PubMed ID: 29089445
[TBL] [Abstract][Full Text] [Related]
17. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
[TBL] [Abstract][Full Text] [Related]
18. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α
Hennenberg M; Acevedo A; Wiemer N; Kan A; Tamalunas A; Wang Y; Yu Q; Rutz B; Ciotkowska A; Herlemann A; Strittmatter F; Stief CG; Gratzke C
Prostate; 2017 May; 77(7):697-707. PubMed ID: 28116771
[TBL] [Abstract][Full Text] [Related]
19. Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover.
Elliot SJ; Zorn BH; McLeod DG; Moul JW; Nyberg L; Striker LJ; Striker GE
Prostate Cancer Prostatic Dis; 2003; 6(2):138-42. PubMed ID: 12806372
[TBL] [Abstract][Full Text] [Related]
20. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis.
Shapiro E; Hartanto V; Lepor H
J Urol; 1992 Apr; 147(4):1167-70. PubMed ID: 1372663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
